Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

New punch technologies have improved hair transplant results over time.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Hair restoration surgery has a growing risk of hair loss over time.

Hair transplant techniques have improved and become less invasive over time, but there are concerns about unregulated centers. The market is growing, with potential for more growth in India due to increasing hair loss cases. New technologies like robotic transplants are promising for the future. Surgeons are encouraged to prioritize patient safety and understand the science behind their techniques.

Hair loss after weight loss surgery can improve over time.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Most patients with cutaneous dermatomyositis either improved or remained stable over 3.5 years.

Oxidized hair can naturally regain strength and stability over six months.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

A new microneedle patch can help regrow hair over a long time.

A 36-year-old woman with worsening hair loss over 10 years was treated with various medications, and after six months, her hair loss did not worsen significantly.

A stable and simple finasteride suspension was developed that retains over 94.3% of its concentration for up to 90 days and doesn't significantly increase occupational exposure, but safety measures are still advised.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Patients with this syndrome can have different responses and worsening resistance to treatment over time.

Hair can regrow after certain stem cells are lost because other stem cells can take over their role.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Leg hair transplants can create a natural-looking hairline and show successful growth over several years.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Minoxidil 5% solution significantly improved hair density in a girl with loose anagen hair syndrome over 28 months, with no side effects.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.